Videos / Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
Eczema Management Practical Tips
Oral Contraception Updates
Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes
Menopausal Hormone Therapy and its Cardiovascular Benefits
expert
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health